Evidence map›Paper›PMID 26768185›Full record

ReviewAmerican journal of medical genetics. Part A2015

De novo 9q gain in an infant with tetralogy of Fallot with absent pulmonary valve: Patient report and review of congenital heart disease in 9q duplication syndrome.

Ina E Amarillo, Shawn O'Connor, Caroline K Lee, Marcia Willing, Jennifer A Wambach

Open access · greenAbstract readCase ReportsReview
In one paragraph

Review in American journal of medical genetics. Part A, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
9.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ina E AmarilloDepartment of Pathology and Immunology, Cytogenomics Laboratory, Washington University in St. Louis School of Medicine, St. Louis, Missouri.
Shawn O'ConnorDepartment of Pediatrics, Washington University in St. Louis School of Medicine, St. Louis, Missouri.
Caroline K LeeDepartment of Pediatrics, Washington University in St. Louis School of Medicine, St. Louis, Missouri.
Marcia WillingDepartment of Pediatrics, Washington University in St. Louis School of Medicine, St. Louis, Missouri.
Jennifer A WambachDepartment of Pediatrics, Washington University in St. Louis School of Medicine, St. Louis, Missouri.
Washington University in St. Louis · US

Funding

SURFACTANT PATHWAY GENE VARIANTS AMONG INFANTS WITH RESPIRATORY DISTRESS SYNDROMEK08HL105891 · NHLBI · WASHINGTON UNIVERSITY · PI WAMBACH, JENNIFER · 2011 to 2013
$377k
NHLBI NIH HHS K08 HL105891
6 · The paper itself

Abstract

Genomic disruptions, altered epigenetic mechanisms, and environmental factors contribute to the heterogeneity of congenital heart defects (CHD). In recent years, chromosomal microarray analysis (CMA) has led to the identification of numerous copy number variations (CNV) in patients with CHD. Genes disrupted by and within these CNVs thus represent excellent candidate genes for CHD. Microduplications of 9q (9q+) have been described in patients with CHD, however, the critical gene locus remains undetermined. Here we discuss an infant with tetralogy of Fallot with absent pulmonary valve, fetal hydrops, and a 3.76 Mb de novo contiguous gain of 9q34.2-q34.3 detected by CMA, and confirmed by karyotype and FISH studies. This duplicated interval disrupted RXRA (retinoid X receptor alpha; OMIM #180245) at intron 1. We also review CHD findings among previously reported patients with 9q (9q+) duplication syndrome. This is the first report implicating RXRA in CHD with 9q duplication, providing additional data in understanding the genetic etiology of tetralogy of Fallot, CHD, and disorders linked to 9q microduplication syndrome. This report also highlights the significance of CMA in the clinical diagnosis and genetic counseling of patients and families with complex CHD.

Indexed as

TrisomyChromosomes, Human, Pair 9FemaleHeart Defects, CongenitalHumansInfant, NewbornPulmonary ValveRetinoid X Receptor alphaTetralogy of FallotRetinoid X Receptor alpharetinoid X receptor alphaRXRAtetralogy of Fallot with absent pulmonary valve

Identifiers

PMID26768185
PMCPMC8792801
OpenAlexW1718192940

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.